Selenium inhibits proliferation signaling and restores sodium/potassium pump function of diabetic rat aorta

Biological Trace Element Research

Volumn 126, Issue 1-3, 2008, Pages 237-245

  Aydemir Koksoy, Aslihan ^a   Turan, Belma ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Caveolin1; Diabetes; Selenium; Sodium potassium pump; Vascular smooth muscle

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CAVEOLIN 1; METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; SELENATE; SELENIUM; CAV PROTEIN, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; AORTA; ARTICLE; CELL CULTURE; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HOMOGENATE; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; VASCULAR SMOOTH MUSCLE; ANIMAL; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; METABOLISM;

ANIMALIA; RATTUS;

ANIMALS; AORTA; CAVEOLIN 1; DIABETES MELLITUS, EXPERIMENTAL; MALE; RATS; SELENIUM; SODIUM-POTASSIUM-EXCHANGING ATPASE;

EID: 64849089078     PISSN: 01634984     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12011-008-8206-8     Document Type: Article

References (45)

1. MA Creager TF Luscher F Cosentino JA Beckman 2003 Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I Circulation 108 1527 1532 (Pubitemid 37176462)
2. JA Beckman MA Creager P Libby 2002 Diabetes and atherosclerosis: epidemiology, pathophysiology, and management JAMA 287 2570 2581 (Pubitemid 34517204)
3. ME Ryan A Usman NS Ramamurthy LM Golub RA Greenwald 2001 Excessive matrix metalloproteinase activity in diabetes: inhibition by tetracycline analogues with zinc reactivity Curr Med Chem 8 305 316 (Pubitemid 32409782)
4. S Yamagishi T Imaizumi 2005 Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy Curr Pharm Des 11 2279 2299 (Pubitemid 40872698)
5. H Gobel AC van der Wal P Teeling CM van der Loos AE Becker 2000 Metallothionein in human atherosclerotic lesions: a scavenger mechanism for reactive oxygen species in the plaque? Virchows Arch 437 528 533
6. TE Bunton NJ Biery L Myers B Gayraud F Ramirez HC Dietz 2001 Phenotypic alteration of vascular smooth muscle cells precedes elastolysis in a mouse model of Marfan syndrome Circ Res 88 37 43 (Pubitemid 32064080)
7. P Etienne N Pares-Herbute L Mani-Ponset J Gabrion H Rabesandratana S Herbute L Monnier 1998 Phenotype modulation in primary cultures of aortic smooth muscle cells from streptozotocin-diabetic rats Differentiation 63 225 236 (Pubitemid 28428736)
8. JD Raffetto RA Khalil 2008 Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease Biochem Pharmacol 75 346 359 (Pubitemid 350298459)
9. IJ Goldberg HM Dansky 2006 Diabetic vascular disease: an experimental objective Arterioscler Thromb Vasc Biol 26 1693 1701 (Pubitemid 44305321)
10. L Michea V Irribarra IA Goecke ET Marusic 2001 Reduced Na-K pump but increased Na-K-2Cl cotransporter in aorta of streptozotocin-induced diabetic rat Am J Physiol Heart Circ Physiol 280 H851 H858 (Pubitemid 32466930)
11. +/K(+)-ATPase activity in vascular smooth muscle from streptozotocin diabetic rat Cardiovasc Res 34 137 144 (Pubitemid 27261922)
12. S Iannello P Milazzo F Belfiore 2007 Animal and human tissue Na,K-ATPase in obesity and diabetes: a new proposed enzyme regulation Am J Med Sci 333 1 9 (Pubitemid 46104866)
13. C Douillet M Bost M Accominotti F Borson-Chazot M Ciavatti 1998 Effect of selenium and vitamin E supplements on tissue lipids, peroxides, and fatty acid distribution in experimental diabetes Lipids 33 393 399 (Pubitemid 28217385)
14. P Faure 2003 Protective effects of antioxidant micronutrients (vitamin E, zinc and selenium) in type 2 diabetes mellitus Clin Chem Lab Med 41 995 998 (Pubitemid 37062988)
15. AE Slonim ML Surber DL Page RA Sharp IM Burr 1983 Modification of chemically induced diabetes in rats by vitamin E. Supplementation minimizes and depletion enhances development of diabetes J Clin Invest 71 1282 1288
16. B Turan NL Acan NN Ulusu EF Tezcan 2001 A comparative study on effect of dietary selenium and vitamin E on some antioxidant enzyme activities of liver and brain tissues Biol Trace Elem Res 81 141 152 (Pubitemid 32777776)
17. C Jiang W Jiang C Ip H Ganther J Lu 1999 Selenium-induced inhibition of angiogenesis in mammary cancer at chemopreventive levels of intake Mol Carcinog 26 213 225
18. +-ATPase activity as a mechanism of neuronal death mediated by concurrent ATP deficiency and oxidant stress J Cell Sci 116 2099 2110 (Pubitemid 36622306)
19. AG Therien R Blostein 2000 Mechanisms of sodium pump regulation Am J Physiol Cell Physiol 279 C541 C566
20. G Grenier M Remy-Zolghadri R Guignard F Bergeron R Labbe FA Auger L Germain 2003 Isolation and culture of the three vascular cell types from a small vein biopsy sample In Vitro Cell Dev Biol Anim 39 131 139 (Pubitemid 37204096)
21. CQ Gao G Sawicki WL Suarez-Pinzon T Csont M Wozniak P Ferdinandy R Schulz 2003 Matrix metalloproteinase-2 mediates cytokine-induced myocardial contractile dysfunction Cardiovasc Res 57 426 433 (Pubitemid 36144221)
22. F Ismail-Beigi IS Edelman 1971 The mechanism of the calorigenic action of thyroid hormone. Stimulation of Na plus + K plus-activated adenosinetriphosphatase activity J Gen Physiol 57 710 722
23. A Aydemir-Koksoy J Abramowitz JC Allen 2001 Ouabain-induced signaling and vascular smooth muscle cell proliferation J Biol Chem 276 46605 46611 (Pubitemid 37370923)
24. J Abramowitz C Dai KK Hirschi RI Dmitrieva PA Doris L Liu JC Allen 2003 Ouabain- and marinobufagenin-induced proliferation of human umbilical vein smooth muscle cells and a rat vascular smooth muscle cell line, A7r5 Circulation 108 3048 3053 (Pubitemid 37553577)
25. P Deedwania S Srikanth 2008 Diabetes and vascular disease Expert Rev Cardiovasc Ther 6 127 138
26. R Natarajan JL Nadler 2003 Lipoxygenases and lipid signaling in vascular cells in diabetes Front Biosci 8 s783 s795 (Pubitemid 39140196)
27. G Spinetti N Kraenkel C Emanueli P Madeddu 2008 Diabetes and vessel wall remodelling: from mechanistic insights to regenerative therapies Cardiovasc Res 78 265 273
28. NC Schaper MH Nabuurs-Franssen MS Huijberts 2000 Peripheral vascular disease and type 2 diabetes mellitus Diabetes Metab Res Rev 16 Suppl 1 S11 S15
29. W Song A Ergul 2006 Type-2 diabetes-induced changes in vascular extracellular matrix gene expression: relation to vessel size Cardiovasc Diabetol 5 3
30. AK Chow J Cena R Schulz 2007 Acute actions and novel targets of matrix metalloproteinases in the heart and vasculature Br J Pharmacol 152 189 205 (Pubitemid 47517601)
31. RD Kenagy CE Hart WG Stetler-Stevenson AW Clowes 1997 Primate smooth muscle cell migration from aortic explants is mediated by endogenous platelet-derived growth factor and basic fibroblast growth factor acting through matrix metalloproteinases 2 and 9 Circulation 96 3555 3560 (Pubitemid 27513433)
32. M Seiki 2002 The cell surface: the stage for matrix metalloproteinase regulation of migration Curr Opin Cell Biol 14 624 632 (Pubitemid 35247747)
33. S Rajagopalan XP Meng S Ramasamy DG Harrison ZS Galis 1996 Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability J Clin Invest 98 2572 2579 (Pubitemid 26415078)
34. T Okamoto T Akaike T Sawa Y Miyamoto A van der Vliet H Maeda 2001 Activation of matrix metalloproteinases by peroxynitrite-induced protein S-glutathiolation via disulfide S-oxide formation J Biol Chem 276 29596 29602 (Pubitemid 37452059)
35. L Campbell M Gumbleton K Ritchie 2001 Caveolae and the caveolins in human disease Adv Drug Deliv Rev 49 325 335 (Pubitemid 32718692)
36. G Garcia-Cardena P Martasek BS Masters PM Skidd J Couet S Li MP Lisanti WC Sessa 1997 Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the nos caveolin binding domain in vivo J Biol Chem 272 25437 25440 (Pubitemid 27438846)
37. M Bucci F Roviezzo V Brancaleone MI Lin A Di Lorenzo C Cicala A Pinto WC Sessa S Farneti S Fiorucci G Cirino 2004 Diabetic mouse angiopathy is linked to progressive sympathetic receptor deletion coupled to an enhanced caveolin-1 expression Arterioscler Thromb Vasc Biol 24 721 726 (Pubitemid 38451610)
38. JL Evans ID Goldfine BA Maddux GM Grodsky 2002 Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes Endocr Rev 23 599 622 (Pubitemid 35191625)
39. M Awazu K Ishikura M Hida M Hoshiya 1999 Mechanisms of mitogen-activated protein kinase activation in experimental diabetes J Am Soc Nephrol 10 738 745 (Pubitemid 29149523)
40. SH Kim VJ Johnson TY Shin RP Sharma 2004 Selenium attenuates lipopolysaccharide-induced oxidative stress responses through modulation of p38 MAPK and NF-kappaB signaling pathways Exp Biol Med (Maywood) 229 203 213 (Pubitemid 38146564)
41. KP Sarker KK Biswas JL Rosales K Yamaji T Hashiguchi KY Lee I Maruyama 2003 Ebselen inhibits NO-induced apoptosis of differentiated PC12 cells via inhibition of ASK1-p38 MAPK-p53 and JNK signaling and activation of p44/42 MAPK and Bcl-2 J Neurochem 87 1345 1353 (Pubitemid 38020569)
42. YY Bagrov NB Manusova IA Egorova OV Fedorova AY Bagrov 2005 Endogenous digitalis-like ligands and Na/K-ATPase inhibition in experimental diabetes mellitus Front Biosci 10 2257 2262 (Pubitemid 40905297)
43. + pump activity in vascular smooth muscle cells Ann N Y Acad Sci 834 576 578 (Pubitemid 28009130)
44. R Gopalakrishna S Jaken 2000 Protein kinase C signaling and oxidative stress Free Radic Biol Med 28 1349 1361 (Pubitemid 30621479)
45. R Sinha SC Kiley JX Lu HJ Thompson R Moraes S Jaken D Medina 1999 Effects of methylselenocysteine on PKC activity, cdk2 phosphorylation and gadd gene expression in synchronized mouse mammary epithelial tumor cells Cancer Lett 146 135 145 (Pubitemid 29492882)